What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Statistics
His main research concerns Internal medicine, Renal function, Kidney disease, Endocrinology and Urology.
Tom Greene frequently studies issues relating to Diabetes mellitus and Internal medicine.
His work deals with themes such as Creatinine, Ramipril, Proteinuria and Disease, which intersect with Renal function.
His research in Kidney disease intersects with topics in Body mass index, Surgery, Cohort study, Cardiology and Intensive care medicine.
The various areas that Tom Greene examines in his Endocrinology study include Gastroenterology and National Health and Nutrition Examination Survey.
Tom Greene has researched Urology in several fields, including Blood urea nitrogen, Interquartile range, Nephropathy, Urinary system and Serum Creatinine Measurement.
His most cited work include:
- A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation (12633 citations)
- A New Equation to Estimate Glomerular Filtration Rate (12427 citations)
- Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. (3982 citations)
What are the main themes of his work throughout his whole career to date?
Tom Greene mainly focuses on Internal medicine, Kidney disease, Renal function, Endocrinology and Surgery.
His Internal medicine research is multidisciplinary, incorporating elements of Diabetes mellitus and Cardiology.
His Kidney disease study also includes fields such as
- Cohort study which connect with Cohort,
- Clinical trial and related Surrogate endpoint.
His studies in Renal function integrate themes in fields like Creatinine, Proteinuria, Disease and Urology.
His Endocrinology research incorporates elements of Gastroenterology and National Health and Nutrition Examination Survey.
His Hemodialysis study incorporates themes from Urea, Dialysis and Confidence interval.
He most often published in these fields:
- Internal medicine (50.30%)
- Kidney disease (33.00%)
- Renal function (26.84%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (50.30%)
- Kidney disease (33.00%)
- Renal function (26.84%)
In recent papers he was focusing on the following fields of study:
Tom Greene mostly deals with Internal medicine, Kidney disease, Renal function, Clinical trial and Randomized controlled trial.
His Internal medicine study integrates concerns from other disciplines, such as Diabetes mellitus, Canagliflozin, Type 2 diabetes and Cardiology.
Tom Greene conducts interdisciplinary study in the fields of Kidney disease and In patient through his research.
The Renal function study combines topics in areas such as Urology, Placebo, Clinical endpoint, Urinary system and Creatinine.
He studies Cystatin C which is a part of Creatinine.
His Randomized controlled trial research is multidisciplinary, relying on both Psychological intervention, Physical therapy and Comparative effectiveness research.
Between 2018 and 2021, his most popular works were:
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy (1296 citations)
- Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups Results From the Randomized CREDENCE Trial (96 citations)
- Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials (81 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Statistics
Kidney disease, Internal medicine, Renal function, Clinical trial and Diabetes mellitus are his primary areas of study.
Tom Greene has included themes like Gastroenterology, Nephropathy, Confidence interval and Surrogate endpoint in his Kidney disease study.
His Internal medicine research integrates issues from Dapagliflozin and Cardiology.
The concepts of his Renal function study are interwoven with issues in Creatinine, Intensive care medicine, Cohort and Urology.
His Creatinine study focuses on Cystatin C in particular.
Tom Greene interconnects Adverse effect, Randomized controlled trial and Disease in the investigation of issues within Clinical trial.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
